The p.Leu167del variant is known to cause hypercholesterolemia in 3.1% of ADH subjects without LDL, APOB, and PCSK9 mutations in Spain [28] and a French patient among a cohort of 229 ADH subjects [10]. Here, PCSK9 is linked to familial hypercholesterolemia.